2 mg ETH267 (Doxazosin 2 mg)

Pill imprint 2 mg ETH267 has been identified as Doxazosin mesylate 2 mg.

Doxazosin is used in the treatment of high blood pressure; benign prostatic hyperplasia; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 2 mg ETH267 (Doxazosin 2 mg)

Doxazosin mesylate 2 mg 2 mg ETH267 Front
Doxazosin mesylate 2 mg 2 mg ETH267 Back
Doxazosin mesylate 2 mg 2 mg ETH267
Doxazosin mesylate
2 mg
2 mg
Elliptical / Oval
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Ethex Corporation
National Drug Code (NDC):
Inactive Ingredients:
hydrated alumina
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67253-0381 DAVA Pharmaceuticals, Inc.
54569-5169 A S Medication Solutions LLC (repackager)
58016-0997 Southwood Pharmaceuticals Inc (repackager)
33358-0116 Core Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)